Resoimplant GmbH, a Regensburg, Germany-based company that develops, manufactures and markets resorbable double shell expansion systems for secure fixation of tendons, ligaments and bone fragments in orthopaedic, trauma and sports medicine applications, closed a €2,54m financing round.
Backers in the round include a new investor, the Bavarian Investment Company (Bayerische Beteiligungsgesellschaft), and existing shareholders S-Refit, High Tech Gründerfonds, Bayern Kapital, and FVW Beteiligungsgesellschaft GmbH.
The funds will be used to develop international sales and marketing as well as accelerate the new product pipeline, especially a new fixation system for use in shoulder and ankle surgery.
Commenting on the funding, Resoimplant general manager Robert Guilleaume, was quoted as saying: “This investment allows use to introduce our new Resofix Plus system in the key markets in the US and in Europe.
“In addition we can accelerate the product development pipeline to assure a timely market launch of these new systems”.